Viewing SEC Facts Units
Company Name:
Qualigen Therapeutics, Inc.
CIK:
1460702
Start Filing Date:
2022-05-24
End Filing Date:
2022-05-26
ACCN:
0001493152-22-032189
Value:
$ 70,478
Value Error:
$ None
Created By:
Date Filed:
2022-11-14
FY:
2022
Fiscal Period:
Q3
Frame:
CY2021Q3I
Type:
us-gaap
Form:
10-Q
Units:
shares